Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP698432.RAsg0oRwkrGp9udiw-1Ibk6qBT0-qvu9qx37ejxzJazbs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP698432.RAsg0oRwkrGp9udiw-1Ibk6qBT0-qvu9qx37ejxzJazbs130_assertion type Assertion NP698432.RAsg0oRwkrGp9udiw-1Ibk6qBT0-qvu9qx37ejxzJazbs130_head.
- NP698432.RAsg0oRwkrGp9udiw-1Ibk6qBT0-qvu9qx37ejxzJazbs130_assertion description "[Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698432.RAsg0oRwkrGp9udiw-1Ibk6qBT0-qvu9qx37ejxzJazbs130_provenance.
- NP698432.RAsg0oRwkrGp9udiw-1Ibk6qBT0-qvu9qx37ejxzJazbs130_assertion evidence source_evidence_literature NP698432.RAsg0oRwkrGp9udiw-1Ibk6qBT0-qvu9qx37ejxzJazbs130_provenance.
- NP698432.RAsg0oRwkrGp9udiw-1Ibk6qBT0-qvu9qx37ejxzJazbs130_assertion SIO_000772 16633151 NP698432.RAsg0oRwkrGp9udiw-1Ibk6qBT0-qvu9qx37ejxzJazbs130_provenance.
- NP698432.RAsg0oRwkrGp9udiw-1Ibk6qBT0-qvu9qx37ejxzJazbs130_assertion wasDerivedFrom befree-20150227 NP698432.RAsg0oRwkrGp9udiw-1Ibk6qBT0-qvu9qx37ejxzJazbs130_provenance.
- NP698432.RAsg0oRwkrGp9udiw-1Ibk6qBT0-qvu9qx37ejxzJazbs130_assertion wasGeneratedBy ECO_0000203 NP698432.RAsg0oRwkrGp9udiw-1Ibk6qBT0-qvu9qx37ejxzJazbs130_provenance.